» Articles » PMID: 6548209

Different Effects of Hypercalcemic State Induced by Walker Tumor (HWCS 256) and 1,25 (OH)D3 Intoxication on Rat Thyroid C Cells. An Ultrastructural, Immunocytochemical, and Biochemical Study

Overview
Journal Histochemistry
Specialty Biochemistry
Date 1984 Jan 1
PMID 6548209
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Two different models of chronic C cell stimulation by the hypercalcemic state were compared with respect to their morphology, immunocytochemistry, and biochemistry. In the chronic hypercalcemic state due to the HWCS 256 strain of the Walker tumor C cells show signs of degeneration such as vacuolation, on day 7 after tumor implantation. On day 10 tumor induced hypercalcemia leads to irreversible cell damage with karyopyknosis and karyorrhexis. These morphological changes are accompanied by a decline in radioimmunologically measurable calcitonin content of the thyroid and by the loss of response to acute stimulation of C cells. In contrast, in the hypercalcemic state due to 1,25(OH)2D3 intoxication we find an almost complete degranulation of C cells but no signs of degeneration or cell damage, although the thyroid calcitonin content and the calcitonin secretion capacity is greatly reduced. Tumor induced cachexia as a reason for C cell damage in tumor bearing rats could be excluded. Other possible reasons, such as acute overstimulation and tumor factors acting directly on C cells are discussed.

Citing Articles

Chronic hypervitaminosis D3 determines a decrease in C-cell numbers and calcitonin levels in rats.

Martin-Lacave I, Ramos F, Utrilla J, Conde E, Hevia A, Fernandez R J Endocrinol Invest. 1998; 21(2):102-8.

PMID: 9585384 DOI: 10.1007/BF03350323.


Neuron-specific enolase in medullary thyroid carcinoma: immunohistochemical demonstration, but no significance as serum tumor marker.

Grauer A, Raue F, Rix E, Tschahargane C, Ziegler R J Cancer Res Clin Oncol. 1987; 113(6):599-602.

PMID: 3316243 DOI: 10.1007/BF00390873.


Effect of hypercalcemia on parafollicular cells in the rat thyroid gland.

Zabel M, Schafer H Histochemistry. 1988; 88(3-6):623-8.

PMID: 2896647 DOI: 10.1007/BF00570333.

References
1.
Minne H, Raue F, Bellwinkel S, Ziegler R . The hypercalcaemic syndrome in rats bearing the Walker carcinosarcoma 256. Acta Endocrinol (Copenh). 1975; 78(3):613-24. DOI: 10.1530/acta.0.0780613. View

2.
Deftos L, Bury A, Habener J, Singer F, Potts Jr J . Immunoassay for human calcitonin. II. Clinical studies. Metabolism. 1971; 20(12):1129-37. DOI: 10.1016/0026-0495(71)90038-2. View

3.
LETTRE H . [Yoshida sarcoma in rat]. Z Krebsforsch. 1953; 59(3):287-97. View

4.
Adachi I, Abe K, Tanaka M, Yamaguchi K, Miyakawa S . Plasma human calcitonin (hCT) levels in normal and pathologic conditions, and their responses to short calcium or tetragastrin infusion. Endocrinol Jpn. 1976; 23(6):517-26. DOI: 10.1507/endocrj1954.23.517. View

5.
Minne H, Ziegler R, Schmitt W, Hilgard P . [Hypercalcemic activity of Walker carcinosarcoma 256 in the rat]. Schweiz Med Wochenschr. 1971; 101(13):481-3. View